Compositions and methods useful for the treatment of neuromyelitis optica spectrum… Grant US-11938174-B2 United States of America 26 Mar 2024
Antibodies specifically binding to MASP-3 for the treatment of various diseases and… Grant US-11883493-B2 United States of America 30 Jan 2024
RODENTS EXPRESSING HUMANIZED C1Q COMPLEX Application EP-4249502-A3 European Patent Office 06 Dec 2023
ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF Application EP-4252769-A3 European Patent Office 29 Nov 2023
Anti-complement factor C1Q antibodies and uses thereof Grant US-11649279-B2 United States of America 16 May 2023
Polynucleotides encoding anti-C1s antibodies Grant US-11246926-B2 United States of America 15 Feb 2022
Non-human animals expressing humanized C1Q complex Grant US-11186848-B2 United States of America 30 Nov 2021
Antibodies specifically binding to MASP-3 for the treatment of various diseases and… Grant US-11027015-B2 United States of America 08 Jun 2021
Anti-complement factor C1Q antibodies and uses thereof Grant US-10927167-B2 United States of America 23 Feb 2021
Compositions and methods useful for the treatment of neuromyelitis optica spectrum… Grant US-10786557-B2 United States of America 29 Sep 2020
Compositions and therapeutic methods for the treatment of complement-associated diseases Grant US-10772894-B2 United States of America 15 Sep 2020
Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage Grant US-10729767-B2 United States of America 04 Aug 2020
Anti-complement factor C1q Fab fragments and uses thereof Grant US-10723788-B2 United States of America 28 Jul 2020
Antibodies specifically binding to MASP-3 for the treatment of various diseases and… Grant US-10639369-B2 United States of America 05 May 2020
Anti-complement factor C1q antibodies and uses thereof Grant US-10590190-B2 United States of America 17 Mar 2020
Compounds for the prevention and treatment of cardiovascular diseases Grant US-10532054-B2 United States of America 14 Jan 2020
Anti-complement factor C1q antibodies and uses thereof Application AU-2014287221-B2 Australia 12 Sep 2019
ANTI-COMPLEMENT FACTOR C1Q FAB FRAGMENTS AND USES THEREOF Application EP-3380518-A4 European Patent Office 31 Jul 2019
Humanized anti-complement factor C1Q antibodies Grant US-10316081-B2 United States of America 11 Jun 2019
Compositions and methods useful for the treatment of neuromyelitis optica spectrum… Application US-10272142-B2 United States of America 30 Apr 2019
NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX Application WO-2019067706-A1 World Intellectual Property Organisation (WIPO) 04 Apr 2019
Anti-complement factor C1q antibodies and uses thereof Grant US-10227398-B2 United States of America 12 Mar 2019
Compositions and therapeutic methods for the treatment of complement-associated diseases Grant US-10111885-B2 United States of America 30 Oct 2018
Anti-complement factor C1q antibodies and uses thereof Grant US-9708394-B2 United States of America 18 Jul 2017
Anti-complement C1s antibodies and methods of inhibiting complement C1s activity Grant US-9562106-B2 United States of America 07 Feb 2017
Methods of inhibiting complement C4 activation with anti-complement C1s antibodies Grant US-9562092-B2 United States of America 07 Feb 2017
ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF Application EP-3019240-A4 European Patent Office 04 Jan 2017
Anti-complement C1s antibodies and methods of inhibiting complement C1s activity Grant US-9512233-B2 United States of America 06 Dec 2016